Page last updated: 2024-11-05

zonisamide and Dyskinesia Syndromes

zonisamide has been researched along with Dyskinesia Syndromes in 2 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Research Excerpts

ExcerptRelevanceReference
"Treatment with zonisamide was well-tolerated and no participants dropped out prematurely."2.77Effects of zonisamide on tardive dyskinesia: a preliminary open-label trial. ( Irie, S; Iwashita, S; Iwata, Y; Mimura, M; Suzuki, T; Uchida, H; Watanabe, K, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lerner, PP1
Miodownik, C1
Lerner, V1
Iwata, Y1
Irie, S1
Uchida, H1
Suzuki, T1
Watanabe, K1
Iwashita, S1
Mimura, M1

Reviews

1 review available for zonisamide and Dyskinesia Syndromes

ArticleYear
Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.
    Psychiatry and clinical neurosciences, 2015, Volume: 69, Issue:6

    Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; alpha-Tocopherol; Amantadine; Anticonvuls

2015

Trials

1 trial available for zonisamide and Dyskinesia Syndromes

ArticleYear
Effects of zonisamide on tardive dyskinesia: a preliminary open-label trial.
    Journal of the neurological sciences, 2012, Apr-15, Volume: 315, Issue:1-2

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Female; Humans; Isoxazoles; Male; Movement Disorders;

2012